valine and Cancer of Nasopharynx

valine has been researched along with Cancer of Nasopharynx in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Q; Wu, G; Zhao, W1

Other Studies

1 other study(ies) available for valine and Cancer of Nasopharynx

ArticleYear
Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2009, Volume: 18, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cobalt Radioisotopes; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gamma Rays; Humans; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Radiation Tolerance; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Tumor Cells, Cultured; Valine; Valsartan; Vascular Endothelial Growth Factor A

2009